Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis-Reference-Cited by-同舟云学术

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Published:2017-11-06 Issue:10 Volume:70 Page:1634-1643
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Allanore Yannick¹,Distler Oliver²,Jagerschmidt Alexandre³,Illiano Stephane³,Ledein Laetitia³,Boitier Eric⁴,Agueusop Inoncent⁵,Denton Christopher P.⁶,Khanna Dinesh⁷

Affiliation:

1. Rheumatology A department; Cochin Hospital; Paris Descartes University; Paris France

2. University Hospital Zurich; Zurich Switzerland

3. Sanofi R&D; Chilly-Mazarin France

4. Sanofi R&D; Alfortville France

5. Sanofi R&D; Frankfurt am Main Germany

6. Royal Free Hospital; London UK

7. University of Michigan; Ann Arbor

Funder

Sanofi

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40547/fullpdf

Reference27 articles.

1. Systemic sclerosis: from pathogenesis to targeted therapy;Denton;Clin Exp Rheumatol,2015

2. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies;Elhai;Rheumatology (Oxford),2012

3. Old medications and new targeted therapies in systemic sclerosis;Nagaraja;Rheumatology (Oxford),2015

4. Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling;Zhao;Biochim Biophys Acta,2013

5. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist;Swaney;J Pharmacol Exp Ther,2011

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spotlight on plasticity-related genes: Current insights in health and disease;Pharmacology & Therapeutics;2024-08

2. Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications;International Journal of Molecular Sciences;2024-07-15

3. Lysophosphatidic acid metabolism and signaling in heart disease;Canadian Journal of Physiology and Pharmacology;2024-07-05

4. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

5. Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments;Lipids in Health and Disease;2024-06-28